Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

245.37
Delayed Data
As of Feb 24
 -1.66 / -0.67%
Today’s Change
184.50
Today|||52-Week Range
301.32
+16.84%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues8.7B13.1B15.1B14.6B
 
 
 
 
 
Cost of Goods Sold4.4B6.1B4.6B1.9B
 
 
 
 
 
Depreciation And Amortization1.0B2.8B5.6B--
 
 
 
 
 
Operating ExpensesGross Income3.2B4.2B4.9B12.7B
 
 
 
 
 
General Expenses2.5B4.2B5.7B7.3B
 
 
 
 
 
Other Operating Expenses0.000.000.006.5B
 
 
Research And Development599.4M1.1B2.1B2.6B
 
 
 
 
 
Total Operating Expenses8.0B13.1B15.9B15.6B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income722.4M-26.7M-834.3M-1.1B
 
 
 
 
 
Extraordinary Credit14.9M102.1M31.0M--
 
 
 
 
Extraordinary Charge-1.1B-1.1B-2.2B-743.9M
 
 
 
 
 
Pre-Tax Equity Earnings6.0M------
 
 
Interest Expense On Debt239.8M485.4M1.5B1.3B
 
 
 
 
 
Other Expenses-8.3M-188.6M-10.1M214.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-638.4M-1.7B-4.4B-2.8B
 
 
 
 
 
Income Taxes-112.7M-81.9M-1.6B-1.9B
 
 
 
 
 
Minority Interest-700.0K-300.0K-4.2M-6.1M
 
 
 
 
 
Preferred Dividend0.000.00-232.0M-278.4M
 
 
 
Discontinued Operations0.000.006.8B15.9B
 
 
 
Net Income-750.4M-1.6B3.9B15.0B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS142.3M219.7M367.8M384.9M
 
 
 
 
 
Shares To Calculate EPS Diluted142.3M219.7M367.8M384.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$5.27-$7.42$10.01$38.18
 
 
 
 
 
EPS Diluted-$5.27-$7.42$10.01$38.18